ATC code - B02A
SpainAntifibrinolytics
Drugs with code B02A
-
Form: tablets, film-coated
Active substance Dosage tranexamic acid 500 mg ATC code: B02A, B02AA, B02AA02
Manufacturer: Viatris Healthcare Limited
-
Form: solution for injection
Active substance Dosage tranexamic acid 500 mg ATC code: B02A, B02AA, B02AA02
Manufacturer: Viatris Healthcare Limited
-
Form: solution for injection
Active substance Dosage tranexamic acid 100 mg/ml ATC code: B02A, B02AA, B02AA02
Manufacturer: Medochemie Limited
-
Form: powder and solvent for solution for infusion
Active substance Dosage alpha-1 proteinase inhibitor 1000 mg ATC code: B02A, B02AB, B02AB02
Manufacturer: Instituto Grifols S.A.
-
Form: powder and solvent for solution for infusion
Active substance Dosage alpha-1 proteinase inhibitor 4.000 mg ATC code: B02A, B02AB, B02AB02
Manufacturer: Instituto Grifols S.A.
-
Form: powder and solvent for solution for infusion
Active substance Dosage alfa-1-antitripsina 1000 mg ATC code: B02A, B02AB, B02AB02
Manufacturer: Grifols Deutschland Gmbh
-
Form: powder and solvent for solution for infusion
Active substance Dosage alfa-1-antitripsina 4.000 mg ATC code: B02A, B02AB, B02AB02
Manufacturer: Grifols Deutschland Gmbh
-
Form: powder and solvent for solution for infusion
Active substance Dosage alfa-1-antitripsina 5.000 mg ATC code: B02A, B02AB, B02AB02
Manufacturer: Grifols Deutschland Gmbh
-
Form: powder and solvent for solution for infusion
Active substance Dosage alpha-1 proteinase inhibitor 1000 mg ATC code: B02A, B02AB, B02AB02
Manufacturer: Csl Behring Gmbh
-
Form: powder and solvent for solution for infusion
Active substance Dosage alpha-1 proteinase inhibitor 50 mg/ml ATC code: B02A, B02AB, B02AB02
Manufacturer: Csl Behring Gmbh
-
Form: powder and solvent for solution for infusion
Active substance Dosage alpha-1 proteinase inhibitor 50 mg/ml ATC code: B02A, B02AB, B02AB02
Manufacturer: Csl Behring Gmbh
-
Form: tablets, film-coated
Active substance Dosage tranexamic acid 500 mg ATC code: B02A, B02AA, B02AA02
Manufacturer: Zentiva K.S.